CapitalHeight Market Live: Nifty below 10,700, Sensex falls 200 pts; midcap underperforms

CapitalHeight Review, CapitalHeight Complain, CapitalHeight Complaint, CapitalHeight, bank nifty levels, bank nifty support levels, CapitalHeight Complain, Capitalheight Complaint, clossing bell, daily nifty, free nifty live, free nifty tips, free nifty view, Indian Rupee Update, nifty, nifty down, nifty index, nifty live, Nifty Market Trend, nifty market trends, nifty related news, nifty report, nifty support, nifty support levels, nifty up, nifty up or down, nifty view today, nifty50, nifty50 news

Glenmark Pharma receives ANDA approval: Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Azelaic Acid Gel, 15%, a generic version of Finacea Gel, 15%, of Leo Pharma A/S.

The Sensex is down 232.98 points at 35541.90, while Nifty is down 81.40 points at 10,682. About 826 shares have advanced, 1505 shares declined, and 129 shares are unchanged.

Leave a Reply